Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy
Abstract Background Lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC) are bioactive lysophospholipids involved in the pathogenesis of renal diseases, especially the renal fibrosis. Plasma LPC concentrations in chronic kidney disease (CKD) patients are lower or similar to those observed i...
Main Authors: | Anna Michalczyk, Barbara Dołęgowska, Rafał Heryć, Dariusz Chlubek, Krzysztof Safranow |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-019-1040-5 |
Similar Items
-
Synthesis of Lysophospholipids
by: Paola D’Arrigo, et al.
Published: (2010-03-01) -
Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
by: Yan Xu
Published: (2018-07-01) -
Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters
by: Anna Michalczyk, et al.
Published: (2017-07-01) -
Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer’s Disease: From Physiological Performance to Pathological Impairment
by: Yining Hao, et al.
Published: (2020-04-01) -
Critical Roles of Lysophospholipid Receptors in Activation of Neuroglia and Their Neuroinflammatory Responses
by: Bhakta Prasad Gaire, et al.
Published: (2021-07-01)